Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.
Di Costanzo A, D'Erasmo L, Polimeni L, Baratta F, Coletta P, Di Martino M, Loffredo L, Perri L, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Catalano C, Maranghi M, Del Ben M, Angelico F, Arca M. Di Costanzo A, et al. Atherosclerosis. 2017 Feb;257:232-239. doi: 10.1016/j.atherosclerosis.2016.12.018. Epub 2016 Dec 21. Atherosclerosis. 2017. PMID: 28027788
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.
Di Costanzo A, Belardinilli F, Bailetti D, Sponziello M, D'Erasmo L, Polimeni L, Baratta F, Pastori D, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Giannini G, Del Ben M, Angelico F, Arca M. Di Costanzo A, et al. Sci Rep. 2018 Feb 27;8(1):3702. doi: 10.1038/s41598-018-21939-0. Sci Rep. 2018. PMID: 29487372 Free PMC article.
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD).
Di Costanzo A, Ronca A, D'Erasmo L, Manfredini M, Baratta F, Pastori D, Di Martino M, Ceci F, Angelico F, Del Ben M, Pavanello C, Turri M, Calabresi L, Favari E, Arca M. Di Costanzo A, et al. Biomedicines. 2020 Dec 18;8(12):625. doi: 10.3390/biomedicines8120625. Biomedicines. 2020. PMID: 33352841 Free PMC article.
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy.
Mitacchione G, Schiavone M, Curnis A, Arca M, Antinori S, Gasperetti A, Mascioli G, Severino P, Sabato F, Caracciolo MM, Arabia G, D'Erasmo L, Viecca M, Mancone M, Galli M, Forleo GB. Mitacchione G, et al. J Clin Lipidol. 2021 Jan-Feb;15(1):68-78. doi: 10.1016/j.jacl.2020.12.008. Epub 2020 Dec 29. J Clin Lipidol. 2021. PMID: 33390341 Free PMC article. Clinical Trial.
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways.
Cammisotto V, Baratta F, Castellani V, Bartimoccia S, Nocella C, D'Erasmo L, Cocomello N, Barale C, Scicali R, Di Pino A, Piro S, Del Ben M, Arca M, Russo I, Purrello F, Carnevale R, Violi F, Pastori D, Pignatelli P. Cammisotto V, et al. Int J Mol Sci. 2021 Jul 3;22(13):7193. doi: 10.3390/ijms22137193. Int J Mol Sci. 2021. PMID: 34281247 Free PMC article.
71 results